Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035136416> ?p ?o ?g. }
- W3035136416 endingPage "1511" @default.
- W3035136416 startingPage "1511" @default.
- W3035136416 abstract "In recent years, neoadjuvant treatment trials have shown that breast cancer subtypes identified on the basis of genomic and/or molecular signatures exhibit different response rates and recurrence outcomes, with the implication that subtype-specific treatment approaches are needed. Estrogen receptor-positive (ER+) breast cancers present a unique set of challenges for determining optimal neoadjuvant treatment approaches. There is increased recognition that not all ER+ breast cancers benefit from chemotherapy, and that there may be a subset of ER+ breast cancers that can be treated effectively using endocrine therapies alone. With this uncertainty, there is a need to improve the assessment and to optimize the treatment of ER+ breast cancers. While pathology-based markers offer a snapshot of tumor response to neoadjuvant therapy, non-invasive imaging of the ER disease in response to treatment would provide broader insights into tumor heterogeneity, ER biology, and the timing of surrogate endpoint measurements. In this review, we provide an overview of the current landscape of breast imaging in neoadjuvant studies and highlight the technological advances in each imaging modality. We then further examine some potential imaging markers for neoadjuvant treatment response in ER+ breast cancers." @default.
- W3035136416 created "2020-06-19" @default.
- W3035136416 creator A5005226326 @default.
- W3035136416 creator A5009616281 @default.
- W3035136416 creator A5016580708 @default.
- W3035136416 creator A5020390159 @default.
- W3035136416 creator A5034796205 @default.
- W3035136416 creator A5035934168 @default.
- W3035136416 creator A5039388595 @default.
- W3035136416 creator A5043848481 @default.
- W3035136416 creator A5072789687 @default.
- W3035136416 date "2020-06-09" @default.
- W3035136416 modified "2023-10-18" @default.
- W3035136416 title "Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy" @default.
- W3035136416 cites W1129469643 @default.
- W3035136416 cites W1180462140 @default.
- W3035136416 cites W1206024630 @default.
- W3035136416 cites W12086493 @default.
- W3035136416 cites W1500693877 @default.
- W3035136416 cites W1522505461 @default.
- W3035136416 cites W1592649905 @default.
- W3035136416 cites W1595601103 @default.
- W3035136416 cites W1755737817 @default.
- W3035136416 cites W1809083310 @default.
- W3035136416 cites W1878299132 @default.
- W3035136416 cites W1905012638 @default.
- W3035136416 cites W1930049574 @default.
- W3035136416 cites W1963755646 @default.
- W3035136416 cites W1964045609 @default.
- W3035136416 cites W1969845427 @default.
- W3035136416 cites W1970497617 @default.
- W3035136416 cites W1978936622 @default.
- W3035136416 cites W1981377988 @default.
- W3035136416 cites W1982474740 @default.
- W3035136416 cites W1986516275 @default.
- W3035136416 cites W1987036565 @default.
- W3035136416 cites W1987054640 @default.
- W3035136416 cites W1988673436 @default.
- W3035136416 cites W1991083138 @default.
- W3035136416 cites W1994793426 @default.
- W3035136416 cites W1995579320 @default.
- W3035136416 cites W1996212324 @default.
- W3035136416 cites W1998885723 @default.
- W3035136416 cites W1999463736 @default.
- W3035136416 cites W1999527920 @default.
- W3035136416 cites W2002145465 @default.
- W3035136416 cites W2003237182 @default.
- W3035136416 cites W2006816753 @default.
- W3035136416 cites W2007260291 @default.
- W3035136416 cites W2007817255 @default.
- W3035136416 cites W2008108075 @default.
- W3035136416 cites W2013373169 @default.
- W3035136416 cites W2014339909 @default.
- W3035136416 cites W2018445950 @default.
- W3035136416 cites W2034505940 @default.
- W3035136416 cites W2036387293 @default.
- W3035136416 cites W2037707039 @default.
- W3035136416 cites W2038074788 @default.
- W3035136416 cites W2038833688 @default.
- W3035136416 cites W2039992838 @default.
- W3035136416 cites W2042806233 @default.
- W3035136416 cites W2044702943 @default.
- W3035136416 cites W2048002869 @default.
- W3035136416 cites W2050522518 @default.
- W3035136416 cites W2052268149 @default.
- W3035136416 cites W2055575746 @default.
- W3035136416 cites W2056609529 @default.
- W3035136416 cites W2058585724 @default.
- W3035136416 cites W2061588268 @default.
- W3035136416 cites W2063322236 @default.
- W3035136416 cites W2068554135 @default.
- W3035136416 cites W2071473902 @default.
- W3035136416 cites W2075218696 @default.
- W3035136416 cites W2075660225 @default.
- W3035136416 cites W2075894019 @default.
- W3035136416 cites W2084303018 @default.
- W3035136416 cites W2084775477 @default.
- W3035136416 cites W2085149684 @default.
- W3035136416 cites W2085177488 @default.
- W3035136416 cites W2087562335 @default.
- W3035136416 cites W2092327377 @default.
- W3035136416 cites W2094344237 @default.
- W3035136416 cites W2095627442 @default.
- W3035136416 cites W2096145980 @default.
- W3035136416 cites W2096393323 @default.
- W3035136416 cites W2097255042 @default.
- W3035136416 cites W2097475056 @default.
- W3035136416 cites W2100303404 @default.
- W3035136416 cites W2102120092 @default.
- W3035136416 cites W2103004421 @default.
- W3035136416 cites W2104208496 @default.
- W3035136416 cites W2108043112 @default.
- W3035136416 cites W2108184788 @default.
- W3035136416 cites W2109395529 @default.
- W3035136416 cites W2110204976 @default.
- W3035136416 cites W2111253826 @default.
- W3035136416 cites W2112478842 @default.
- W3035136416 cites W2115546724 @default.